TEK and cancer: Tie2-expressing monocytes (TEMs) are a proangiogenic subpopulation of peripheral and tumor-infiltrating myeloid cells, which have been reported in several angiogenesis-mediated cancers, including renal, colorectal, pancreatic and lung carcinoma, as well as HCC.